Skip to main content
Premium Trial:

Request an Annual Quote

It's Comeuppance Time

The US Federal Trade Commission is taking a swing at companies that promote cancer cures online, reports the Los Angeles Times. The director of the FTC's Bureau of Consumer Protection, Lydia Parnes, says they will be taking action against 11 companies. "We found all of these claims to be nothing short of breathtaking, and not in a good way," she says. One company, Omega Supply, allegedly sold hydrazine sulfate, a carcinogen, and another, Herbs for Cancer, allegedly sold different types of tea as cancer cures. FDA also said they may take a look at the companies.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.